Stock Analysis on Net

Stryker Corp. (NYSE:SYK)

This company has been moved to the archive! The financial data has not been updated since April 29, 2022.

Analysis of Profitability Ratios
Quarterly Data

Microsoft Excel

Profitability Ratios (Summary)

Stryker Corp., profitability ratios (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Return on Sales
Gross profit margin 64.22% 64.11% 63.83% 64.38% 62.75% 63.11% 63.59% 63.34% 65.15% 65.14% 64.95% 65.29% 65.47% 65.72% 65.69% 65.55% 65.58% 65.68%
Operating profit margin 14.76% 15.10% 15.08% 17.23% 13.91% 15.49% 17.00% 15.54% 18.86% 18.23% 16.96% 17.00% 17.83% 18.65% 19.22% 19.16% 18.28% 18.40%
Net profit margin 11.56% 11.66% 11.40% 12.82% 9.57% 11.14% 12.35% 11.38% 14.47% 13.99% 23.55% 24.99% 25.38% 26.12% 9.31% 8.28% 8.00% 8.20%
Return on Investment
Return on equity (ROE) 13.39% 13.40% 13.40% 15.07% 10.43% 12.22% 13.52% 12.55% 16.50% 16.26% 27.82% 29.72% 30.12% 30.29% 12.54% 11.42% 11.06% 10.23%
Return on assets (ROA) 5.58% 5.76% 5.56% 6.18% 4.21% 4.66% 5.44% 5.09% 7.35% 6.90% 12.85% 13.47% 13.58% 13.05% 5.60% 5.01% 4.60% 4.60%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Stryker Corp. gross profit margin ratio improved from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Stryker Corp. operating profit margin ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Stryker Corp. net profit margin ratio improved from Q3 2021 to Q4 2021 but then slightly deteriorated from Q4 2021 to Q1 2022.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Stryker Corp. ROE improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.
ROA A profitability ratio calculated as net income divided by total assets. Stryker Corp. ROA improved from Q3 2021 to Q4 2021 but then slightly deteriorated from Q4 2021 to Q1 2022 not reaching Q3 2021 level.

Gross Profit Margin

Stryker Corp., gross profit margin calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Gross profit 2,734 3,045 2,642 2,772 2,509 2,717 2,461 1,548 2,331 2,703 2,330 2,380 2,283 2,456 2,155 2,190 2,137 2,239 1,982 1,990 1,962
Net sales 4,275 4,701 4,160 4,294 3,953 4,262 3,737 2,764 3,588 4,131 3,587 3,650 3,516 3,796 3,242 3,322 3,241 3,471 3,006 3,012 2,955
Profitability Ratio
Gross profit margin1 64.22% 64.11% 63.83% 64.38% 62.75% 63.11% 63.59% 63.34% 65.15% 65.14% 64.95% 65.29% 65.47% 65.72% 65.69% 65.55% 65.58% 65.68%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories 52.44% 52.21% 52.01% 50.69% 51.25% 50.49% 50.18% 50.97% 52.13% 52.46%
Cigna Group 12.30% 12.41% 12.77% 13.13% 14.04% 14.43% 15.05% 15.49% 15.30% 15.57%
CVS Health Corp. 17.35% 17.48% 17.35% 17.43% 17.99% 18.01% 18.10% 18.16% 17.51% 17.41%
Danaher Corp. 60.77% 60.95% 60.44% 59.24% 57.60% 55.98% 55.04% 55.28% 55.85% 55.74%
Elevance Health Inc. 16.89% 17.09% 17.30% 17.57% 19.38% 19.71% 20.18% 20.43% 18.70% 18.77%
Intuitive Surgical Inc. 68.84% 69.32% 69.12% 68.69% 66.48% 65.65% 66.44% 67.07% 69.04% 69.45%
Medtronic PLC 66.53% 65.19% 63.85% 64.57% 65.76% 67.41% 68.96% 69.22% 69.62% 70.04% 70.33% 70.40% 70.25% 69.77%
UnitedHealth Group Inc. 23.31% 23.60% 23.75% 23.80% 25.79% 25.62% 25.83% 25.95% 23.52% 23.19%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Gross profit margin = 100 × (Gross profitQ1 2022 + Gross profitQ4 2021 + Gross profitQ3 2021 + Gross profitQ2 2021) ÷ (Net salesQ1 2022 + Net salesQ4 2021 + Net salesQ3 2021 + Net salesQ2 2021)
= 100 × (2,734 + 3,045 + 2,642 + 2,772) ÷ (4,275 + 4,701 + 4,160 + 4,294) = 64.22%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Stryker Corp. gross profit margin ratio improved from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Operating Profit Margin

Stryker Corp., operating profit margin calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Operating income (loss) 447 819 574 732 459 749 859 (20) 635 944 628 613 528 698 576 672 591 712 523 501 554
Net sales 4,275 4,701 4,160 4,294 3,953 4,262 3,737 2,764 3,588 4,131 3,587 3,650 3,516 3,796 3,242 3,322 3,241 3,471 3,006 3,012 2,955
Profitability Ratio
Operating profit margin1 14.76% 15.10% 15.08% 17.23% 13.91% 15.49% 17.00% 15.54% 18.86% 18.23% 16.96% 17.00% 17.83% 18.65% 19.22% 19.16% 18.28% 18.40%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories 20.73% 19.56% 20.04% 18.46% 17.97% 15.48% 13.39% 12.78% 14.18% 14.21%
Cigna Group 4.64% 4.60% 4.59% 4.57% 4.98% 5.12% 5.37% 5.47% 5.18% 5.31%
CVS Health Corp. 4.39% 4.54% 4.75% 4.93% 5.19% 5.19% 5.44% 5.36% 4.89% 4.69%
Danaher Corp. 25.23% 25.35% 24.63% 25.04% 22.30% 18.99% 17.61% 17.37% 18.01% 18.25%
Elevance Health Inc. 5.10% 5.15% 4.91% 3.68% 4.83% 4.97% 5.59% 6.99% 5.47% 5.49%
Humana Inc. 3.73% 3.80% 3.40% 4.97% 6.60% 6.56% 7.77% 6.77% 5.09% 4.96%
Intuitive Surgical Inc. 30.69% 31.89% 32.55% 31.27% 26.01% 24.09% 23.95% 25.86% 30.52% 30.69%
Medtronic PLC 14.78% 14.89% 11.44% 12.77% 14.25% 16.57% 20.67% 20.47% 21.25% 20.51% 20.48% 20.22% 21.70% 22.20%
UnitedHealth Group Inc. 8.19% 8.40% 7.91% 7.73% 9.24% 8.76% 9.55% 9.89% 8.12% 8.19%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Operating profit margin = 100 × (Operating income (loss)Q1 2022 + Operating income (loss)Q4 2021 + Operating income (loss)Q3 2021 + Operating income (loss)Q2 2021) ÷ (Net salesQ1 2022 + Net salesQ4 2021 + Net salesQ3 2021 + Net salesQ2 2021)
= 100 × (447 + 819 + 574 + 732) ÷ (4,275 + 4,701 + 4,160 + 4,294) = 14.76%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Stryker Corp. operating profit margin ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.

Net Profit Margin

Stryker Corp., net profit margin calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Net earnings (loss) 323 662 438 592 302 568 621 (83) 493 725 466 480 412 2,068 590 452 443 (249) 434 391 444
Net sales 4,275 4,701 4,160 4,294 3,953 4,262 3,737 2,764 3,588 4,131 3,587 3,650 3,516 3,796 3,242 3,322 3,241 3,471 3,006 3,012 2,955
Profitability Ratio
Net profit margin1 11.56% 11.66% 11.40% 12.82% 9.57% 11.14% 12.35% 11.38% 14.47% 13.99% 23.55% 24.99% 25.38% 26.12% 9.31% 8.28% 8.00% 8.20%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories 17.35% 16.42% 17.12% 15.85% 15.33% 12.99% 10.50% 9.89% 11.15% 11.56%
Cigna Group 3.07% 3.11% 4.97% 4.93% 5.22% 5.31% 3.40% 3.43% 3.22% 3.35%
CVS Health Corp. 2.68% 2.72% 2.67% 2.60% 2.74% 2.68% 3.00% 3.14% 2.77% 2.59%
Danaher Corp. 21.32% 21.84% 20.97% 21.00% 19.17% 16.36% 18.05% 18.35% 18.13% 16.80%
Elevance Health Inc. 4.37% 4.46% 4.17% 3.32% 3.82% 3.78% 4.26% 5.27% 4.42% 4.66%
Humana Inc. 3.52% 3.54% 3.31% 3.13% 4.78% 4.43% 5.67% 5.00% 3.89% 4.20%
Intuitive Surgical Inc. 27.84% 29.85% 30.78% 31.43% 25.78% 24.33% 24.45% 26.07% 30.11% 30.80%
Medtronic PLC 12.29% 11.97% 10.36% 12.69% 15.80% 16.56% 17.11% 15.11% 14.41% 15.16% 16.10% 7.44% 10.56% 10.36%
UnitedHealth Group Inc. 5.91% 6.06% 5.56% 5.37% 6.46% 6.03% 6.66% 6.94% 5.63% 5.76%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
Net profit margin = 100 × (Net earnings (loss)Q1 2022 + Net earnings (loss)Q4 2021 + Net earnings (loss)Q3 2021 + Net earnings (loss)Q2 2021) ÷ (Net salesQ1 2022 + Net salesQ4 2021 + Net salesQ3 2021 + Net salesQ2 2021)
= 100 × (323 + 662 + 438 + 592) ÷ (4,275 + 4,701 + 4,160 + 4,294) = 11.56%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Stryker Corp. net profit margin ratio improved from Q3 2021 to Q4 2021 but then slightly deteriorated from Q4 2021 to Q1 2022.

Return on Equity (ROE)

Stryker Corp., ROE calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Net earnings (loss) 323 662 438 592 302 568 621 (83) 493 725 466 480 412 2,068 590 452 443 (249) 434 391 444
Total Stryker shareholders’ equity 15,046 14,877 14,178 13,820 13,502 13,084 12,986 12,754 13,115 12,807 12,315 11,943 11,693 11,730 9,860 9,460 9,214 9,966 10,425 10,035 9,704
Profitability Ratio
ROE1 13.39% 13.40% 13.40% 15.07% 10.43% 12.22% 13.52% 12.55% 16.50% 16.26% 27.82% 29.72% 30.12% 30.29% 12.54% 11.42% 11.06% 10.23%
Benchmarks
ROE, Competitors2
Abbott Laboratories 21.82% 19.75% 21.04% 18.86% 17.06% 13.71% 10.78% 10.17% 11.84% 11.86%
Cigna Group 11.69% 11.39% 17.68% 16.73% 17.52% 16.81% 11.03% 11.11% 10.91% 11.26%
CVS Health Corp. 10.83% 10.54% 10.20% 9.83% 10.44% 10.35% 11.56% 12.14% 11.08% 10.39%
Danaher Corp. 13.93% 14.24% 13.54% 13.12% 11.76% 9.17% 9.70% 9.56% 10.53% 9.94%
Elevance Health Inc. 17.36% 16.93% 15.44% 12.10% 13.92% 13.77% 14.61% 17.17% 15.08% 15.15%
Humana Inc. 19.81% 18.24% 16.44% 16.72% 26.23% 24.53% 26.34% 24.29% 21.16% 22.49%
Intuitive Surgical Inc. 13.58% 14.32% 14.80% 14.97% 11.56% 10.90% 11.38% 13.00% 16.30% 16.69%
Medtronic PLC 7.54% 7.01% 5.70% 7.05% 8.77% 9.44% 10.26% 9.23% 8.78% 9.25% 9.87% 4.56% 6.30% 6.12%
UnitedHealth Group Inc. 23.98% 24.09% 21.95% 21.03% 25.42% 23.52% 25.65% 26.87% 24.14% 24.02%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
ROE = 100 × (Net earnings (loss)Q1 2022 + Net earnings (loss)Q4 2021 + Net earnings (loss)Q3 2021 + Net earnings (loss)Q2 2021) ÷ Total Stryker shareholders’ equity
= 100 × (323 + 662 + 438 + 592) ÷ 15,046 = 13.39%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Stryker Corp. ROE improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022.

Return on Assets (ROA)

Stryker Corp., ROA calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selected Financial Data (US$ in millions)
Net earnings (loss) 323 662 438 592 302 568 621 (83) 493 725 466 480 412 2,068 590 452 443 (249) 434 391 444
Total assets 36,137 34,631 34,145 33,698 33,455 34,330 32,286 31,483 29,440 30,167 26,659 26,354 25,937 27,229 22,084 21,570 22,133 22,197 21,485 21,292 20,517
Profitability Ratio
ROA1 5.58% 5.76% 5.56% 6.18% 4.21% 4.66% 5.44% 5.09% 7.35% 6.90% 12.85% 13.47% 13.58% 13.05% 5.60% 5.01% 4.60% 4.60%
Benchmarks
ROA, Competitors2
Abbott Laboratories 10.44% 9.40% 9.82% 8.70% 7.86% 6.20% 4.90% 4.52% 5.36% 5.43%
Cigna Group 3.53% 3.46% 5.44% 5.29% 5.55% 5.44% 3.31% 3.30% 3.18% 3.28%
CVS Health Corp. 3.43% 3.39% 3.23% 3.12% 3.22% 3.11% 3.41% 3.51% 3.13% 2.98%
Danaher Corp. 7.74% 7.73% 7.13% 7.19% 6.30% 4.79% 5.05% 4.86% 4.74% 4.85%
Elevance Health Inc. 6.21% 6.26% 5.63% 4.40% 4.93% 5.28% 5.72% 6.72% 5.80% 6.21%
Humana Inc. 6.55% 6.61% 5.90% 6.52% 9.95% 9.63% 10.79% 9.11% 7.55% 9.31%
Intuitive Surgical Inc. 12.02% 12.58% 13.06% 13.20% 10.17% 9.50% 9.92% 11.24% 14.02% 14.17%
Medtronic PLC 4.23% 3.87% 2.97% 3.69% 4.70% 5.28% 5.73% 5.13% 4.84% 5.16% 5.54% 2.56% 3.53% 3.40%
UnitedHealth Group Inc. 7.89% 8.15% 7.24% 6.90% 8.23% 7.81% 8.76% 8.88% 7.27% 7.96%

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Q1 2022 Calculation
ROA = 100 × (Net earnings (loss)Q1 2022 + Net earnings (loss)Q4 2021 + Net earnings (loss)Q3 2021 + Net earnings (loss)Q2 2021) ÷ Total assets
= 100 × (323 + 662 + 438 + 592) ÷ 36,137 = 5.58%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Stryker Corp. ROA improved from Q3 2021 to Q4 2021 but then slightly deteriorated from Q4 2021 to Q1 2022 not reaching Q3 2021 level.